An Overview of Novel and Emerging Therapies for Inflammatory Bowel Disease

by Sumona Bhattacharya, Raymond K. Cross
Published 2020-12-01

An Unusual Presentation of Baker’s Cyst Rupture in an Inflammatory Bowel Disease Patient

by Gianna Stoleru, Lauren George, Raymond K. Cross, Uni Wong
Published 2020-01-01

Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system.

by Raymond K Cross, Michael Chiorean, Francis Vekeman, Yongling Xiao, Eric Wu, Jingdong Chao, Anthony W Wang
Published 2019-01-01

Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease

by Byron P. Vaughn, Andres J. Yarur, Elliot Graziano, James P. Campbell, Abhik Bhattacharya, Jennifer Y. Lee, Katherine Gheysens, Konstantinos Papamichael, Mark T. Osterman, Adam S. Cheifetz, Raymond K. Cross
Published 2020-09-01